The Pre-Eminent Forum for the European Community to Harness Worldwide ADC Innovation & Collaboration
Alongside ADC’s aspiration of advancing to earlier line patient therapies now becoming a reality, the ADC community is preparing to address the consequences of this clinical success.
With the current clinical landscape saturated across Topo1 and MMAE payloads and crowding around established tumour targets, alongside the anticipation of patient resistance looming, it is crucial to double down on differentiation across the value chain, to secure an effective future landscape of ADC therapies for patients in need.
As the longest-standing and pre-eminent antibody-drug conjugate conference in Europe, the 16th World ADC London's agenda has been infused with global ADC design, development, and production differentiation across the whole value chain.
Featuring novel cytotoxic and non-cytotoxic payloads, dual payload ADCs, bispecific ADCs, non-antibody and fragment conjugates and more – don’t miss the trailblazing innovations to overcome patient resistance mechanisms and push ADCs to earlier line oncology treatments.
End-to-End Content for Everyone Working in ADCs
Whether you are exploring the field or have over a decade of experience, are attending to understand the fundamentals or stay up to date with scientific trends and gain technical insights to enhance your day-to-day work - you can tailor the World ADC London experience to meet your specific needs with forward-thinking, industry-led content spanning:
Track 1:
Discovery
Track 2:
Preclinical & Translation
Track 3:
Clinical Lessons
Track 4:
Process & Analytical Development
Track 5:
Manufacturing & Supply Chain
More Than a Meeting: Make the Most of the World ADC Experience
As over 800 ADC decision-makers from Europe and beyond unite at the first major ADC touchpoint of 2026, make sure you take part in the structured networking and informal socialising activities beyond the scientific programme, including:
One-on-One PartneringTM Meeting Scheduling
Exhibition Booth Networking
Scientific Poster Session
Drinks Reception
Licensing, Partnering & Investment Session
Lunch & Learns
Plan Out Your World ADC London Priority Content
Seminar Day - Monday, 23rd February 2026
Ahead of the main conference days, the seminar day is your perfect opportunity to delve into key ADC challenges and bottlenecks across novel conjugates, toxicity, combinations and reg CMC led by forward-thinking ADC experts:
4th Novel Conjugates Day: Discover novel payloads and targeting moieties to stay ahead of the ADC design curve
3rd Toxicity Day: Characterise and mitigate ADC toxicity to deliver safer and more effective ADCs
4th ADCs in Combination Day: Optimise ADC combination strategy to elevate clinical impact and overcome resistance
2nd Regulatory CMC Day: Understand regulatory expectations to elevate your ADC reg CMC strategy
Main Programme Days - Tuesday, 24th February & Wednesday, 25th February 2026
Headlined with keynote plenary sessions from senior ADC leaders showcasing blockbuster clinical development and discussing future priorities to differentiate ADC performance, the main programme days will deliver cutting-edge, end-end ADC development insights through data-driven presentations from a global faculty across five content tracks:
- Discovery
- Preclinical & Translational
- Clinical Lessons
- Process & Analytical Development
- Manufacturing & Supply Chain
Across both days, you can access structured and informal networking opportunities to reconnect with your peers and meet fresh faces to establish new scientific and business “linkers” as the ADC community reunites to kickstart 2026 ADC development.
After the scientific presentations on Day One, make sure you don’t miss the popular Evening Drinks Reception!
Workshop Day - Thursday, 26th February 2026
Reinvigorated with new insights from the main programme days, continue the conversation with like-minded peers in a series of discussions, debates, and forward-thinking sessions to find solutions to your most pressing challenges in the ADC field.
Taking place in more intimate settings, this is your best opportunity to voice your questions and challenge your peers in these collaborative sessions tailored for beginners in the field and for everyone working on ADCs.
Pick one morning and one afternoon workshop, out of:
- Examining The Need for Novel ADC Payload Mechanisms: What Progress Has Been Made & What is Yet to be Demonstrated?
- Using Computational Approaches for Early-Stage Design & Late-Stage Development of ADCs
- Connecting ADC Design to Performance: How is Each Component Contributing to ADC Clinical Safety & Efficacy?
- Delving Into Strategy & Stakeholder Management to Optimise ADC Outsourcing & Supply Chain
- Deep-Diving into ADC Chemistry Conjugation to Understand the Fundamentals Behind Next-Generation ADC Properties & Design
- Optimising Preclinical Model Deployment & Strategy to Tackle ADC & Novel Conjugate Translational Mismatch
- Navigating Clinical Utility Index Approaches & Clinical Pharmacology Strategy to Optimise ADC Dose Selection
- Understanding Process Control & Scale Up to Develop Robust Processes for Complex Conjugates Across Development Stages
Explore the Full Event Guide
- 800+ Industry Attendees
- 110+ Global Speaker Faculty
- 5 Tracks of End-to-End ADC Content
- Comprehensive One-on-One PartneringTM & Informal Networking Opportunities
- Europe’s Largest & Definitive ADC Forum
Brand New Presenting Companies for 2026:
Explore the Agenda
Hear the latest industry insights and discover cutting-edge, end-to-end ADC content from early discovery to late-stage manufacturing.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.